Citations to this article

Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients.
I Juhasz, … , I M Shih, M Herlyn
I Juhasz, … , I M Shih, M Herlyn
Published November 1, 1993
Citation Information: J Clin Invest. 1993;92(5):2401-2407. https://doi.org/10.1172/JCI116846.
View: Text | PDF
Research Article Article has an altmetric score of 3

Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients.

Abstract

Pemphigus vulgaris is an autoimmune blistering disease that is induced by binding of antibodies to a 130/85-kD protein complex on epidermal keratinocytes. An in vivo experimental model of this disease was developed by reconstituting severe combined immunodeficiency (SCID) mice with 1-10 x 10(7) PBL from patients with naturally occurring pemphigus vulgaris. Of 49 reconstituted mice, 34 (69%) produced human IgG levels of > 0.1 mg/ml. Circulating anti-pemphigus antibodies were found in 20 of the 34 successfully reconstituted mice; 44% of these animals had deposits of human IgG in their own skin after it was traumatized by either heat or cold. Spontaneous pemphigus vulgaris-like blisters associated with human IgG deposits were rarely found in mouse skin. By contrast, allogeneic human skin grafted to 10 to 12 mice before reconstitution with patients' PBL developed pemphigus vulgaris-like lesions containing human IgG deposits. These results demonstrate that SCID mice can serve as a model of an antibody-mediated human autoimmune skin disease.

Authors

I Juhasz, G S Lazarus, G F Murphy, I M Shih, M Herlyn

×

Total citations by year

Year: 2022 2018 2016 2013 2009 2008 2006 2005 2004 2003 2002 2001 2000 1998 1997 1996 1994 Total
Citations: 1 1 1 1 1 2 1 3 1 2 5 2 2 1 2 3 1 30
Citation information

Citations to this article (30)

Title and authors Publication Year
Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc.
Shu Y, Yue X, Wax J, Kasper B, Yin J, Wang X, Zhang L, Ahmadi M, Heidecke H, Müller A, Lamprecht P, Yu X, Riemekasten G, Petersen F 		Arthritis Research & Therapy 2022
A methodological review of induced animal models of autoimmune diseases
X Yu, F Petersen 		Autoimmunity Reviews 2018
Drug Discovery and Evaluation: Pharmacological Assays
FJ Hock 		2016
Bullous Skin Diseases: Classical Types of Autoimmune Diseases
J Damoiseaux 		Scientifica 2013
Mouse models with human immunity and their application in biomedical research
B Zhang, Z Duan, Y Zhao 		Journal of Cellular and Molecular Medicine 2009
Humanized Mice for the Study of Type 1 Diabetes and Beta Cell Function
M King, T Pearson, AA Rossini, LD Shultz, DL Greiner 		Annals of the New York Academy of Sciences 2008
Role of CCL17 in the Generation of Cutaneous Inflammatory Reactions in Hu-PBMC-SCID Mice Grafted with Human Skin
J Gilet, Y Chang, C Chenivesse, B Legendre, H Vorng, C Duez, B Wallaert, H Porte, S Senechal, A Tsicopoulos 		Journal of Investigative Dermatology 2008
Models of pemphigus vulgaris
R Eming, M Hertl 		Drug Discovery Today: Disease Models 2006
Mechanisms of blister induction by autoantibodies
C Sitaru, D Zillikens 		Experimental Dermatology 2005
Autoimmune Diseases of the Skin
M Hertl 		2005
Cicatricial Pemphigoid of the Oropharynx after Allogeneic Stem Cell Transplantation for Relapsed Follicular Lymphoma
Y Aisa, T Mori, T Nakazato, R Yamazaki, J Yamagami, M Amagai, Y Ikeda, S Okamoto 		International Journal of Hematology 2005
Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing
A Kurtz, A Aigner, RH Cabal-Manzano, RE Butler, DR Hood, RB Sessions, F Czubayko, A Wellstein 		Neoplasia (New York, N.Y.) 2004
Chemokines in cutaneous allergic reactions: the SCID model as a powerful tool to evaluate their interest as therapeutical targets
A Tsicopoulos, S Sénéchal, P Nadai, N Ralainirina, AB Tonnel 		Revue Française d'Allergologie et d'Immunologie Clinique 2003
Molecular Biology of B Cells
P Brandtzaeg, HC Morton, ME Lamm 		Molecular Biology of B Cells 2003
CCR3-blocking antibody inhibits allergen-induced eosinophil recruitment in human skin xenografts from allergic patients
S Sénéchal, O Fahy, T Gentina, H Vorng, M Capron, AF Walls, AR McEuen, MG Buckley, Q Hamid, B Wallaert, AB Tonnel, A Tsicopoulos 		Laboratory Investigation 2002
Immunologic and Histopathologic Characterization of an Active Disease Mouse Model for Pemphigus Vulgaris
M Ohyama, M Amagai, K Tsunoda, T Ota, S Koyasu, J Hata, A Umezawa, T Nishikawa 		Journal of Investigative Dermatology 2002
The humanized SCID mouse model to study HLA class II-linked autoimmunity to desmoglein 3 in pemphigus vulgaris
T RAdisch, R Riechers, M Hertl 		British Journal of Dermatology 2002
Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder
TG Salopeka, S Logsettyb, EE Tredgetb 		Journal of the American Academy of Dermatology 2002
Drug Discovery and Evaluation
HG Vogel, WH Vogel, BA Schölkens, J Sandow, G Müller, WF Vogel 		2002
Pemphigus: autoimmune diseases of keratinocyte’s adhesion molecules
P Martel, P Joly 		Clinics in Dermatology 2001
Autoreactive T cells as potential targets for immunotherapy of autoimmune bullous skin diseases1 1Abbreviations: Dsg, desmoglein; EC, extracellular portion; HLA, human leukocyte antigen; IL, interleukin; mAb, monoclonal antibody; PBMC, peripheral blood mononuclear cells; PF, pemphigus foliaceus; PV, pemphigus vulgaris; TH, T-helper
M Hertl, R Riechers 		Clinics in Dermatology 2001
Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus
M Amagai, K Tsunoda, H Suzuki, K Nishifuji, S Koyasu, T Nishikawa 		Journal of Clinical Investigation 2000
Immune modulation in pemphigus vulgaris: role of CD28 and IL-10
P Toto, C Feliciani, P Amerio, H Suzuki, B Wang, GM Shivji, D Woodley, DN Sauder 		Journal of immunology (Baltimore, Md. : 1950) 2000
Tuberculin-induced delayed-type hypersensitivity reaction in a model of hu-PBMC-SCID mice grafted with autologous skin
A Tsicopoulos, J Pestel, O Fahy, H Vorng, F Vandenbusche, H Porte, L Eraldi, A Wurtz, H Akoum, Q Hamid, B Wallaert, AB Tonnel 		The American Journal of Pathology 1998
Human Skin/SCID Mouse Chimeras as an In Vivo Model for Human Cutaneous Mast Cell Hyperplasia
M Christofidou-Solomidou, BJ Longley, D Whitaker-Menezes, SM Albelda, GF Murphy 		Journal of Investigative Dermatology 1997
Vesicle Formation and Follicular Root Sheath Separation in Mice Homozygous for Deleterious Alleles at the Balding (bal) Locus
X Montagutelli, A Lalouette, HJ Boulouis, JL Guenet, JP Sundberg 		Journal of Investigative Dermatology 1997
Mouse Mutations as Animal Models and Biomedical Tools for Dermatological Research
JP Sundberg, LE King 		Journal of Investigative Dermatology 1996
Recombinant Desmoglein 3 Has the Necessary Epitopes to Adsorb and Induce Blister-Causing Antibodies
OM Memar, S Rajaraman, R Thotakura, SK Tyring, JL Fan, GS Seetharamaiah, A Lopez, RE Jordon, BS Prabhakar 		Journal of Investigative Dermatology 1996
A Short of Mice and Men: SCID Mouse-Human Skin Chimeras in Immunology Research
GF Murphy 		Journal of Investigative Dermatology 1996
Can autoimmune diseases be induced in severe combined immunodeficient (SCID) mice?
AO Vladutiu 		Research in Immunology 1994

Advertisement